Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Routine CYP2C19 Genotyping to Adjust Thienopyridine Treatment After Primary PCI for STEMI

Autor: Jean-Sébastien Hulot, Bernard Chevalier, Loic Belle, Guillaume Cayla, Khalife Khalife, François Funck, Romain Berthier, Christophe Piot, Muriel Tafflet, Gilles Montalescot, Loïc Belle, Hervé Le Breton, Emmanuel Teiger, Grégoire Dambrin, K. Khalife, L. Schmutz, F. Funck, R. Berthier, C. Piot, G. Hannebicque, G. Montalescot, T. Lognone, F. De Poli, B. Chevalier, N. Lhoest, M. Schneeberger, N. Delarche, A. Faure, H. Aelion, M. Godin, M. Gilard, B. Ritz, P. Barraud, P. Barnay, L.N. Saïdi, O. Le Dref, P. Garot, G. Range, J. Georges, C. Robin, Y. Cottin, L. Belle, G. Souteyrand, A. Lafont, A. Fournier, P. Dupouy, J. Shayne, P. Chapon, C. Boureux, J.P. Faure, H. Ben Amer, A. Furber, O. Ormezzano, G. Bayet, G. Karrillon, L. Maillard, A. Grenzinger, A. Avran, R. Koning, D. Dumant, X. Lamit, R. Dauphin, L. Drogoul, T. Cuisset, O. Wittenberg, J.P. Peyre, P. Laury, R. Robert

Publikováno v: JACC: Cardiovascular Interventions. 13:621-630

@DrHulot_PARCC Anti-platelet therapy adjustment guided by CYP2C19 genotyping can be done in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4f04ede21f166d59381f72be7a616d4e
https://doi.org/10.1016/j.jcin.2020.01.219

6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin

Autor: Didier Blanchard, Franck Paganelli, Didier Champagnac, Hervé Le Breton, Patrick Dupouy, Raphael Dauphin, Philippe Castellant, Nicolas Delarche, Anne Lyuycx-Bore, Luc Maillard, Róbert Gábor Kiss, Philippe Druelles, Antoine Gommeaux, Jarosław Wójcik, Marie Claude Morice, Michel Schneeberger, Erwan Bressolette, Alain Kermarrec, Joel Sainsous, Paul Barragan, Romain Didier, Olivier Darremont, Hakim Ben Amer, Gilles Levy, Alain Furber, Thomas Hovasse, Martine Gilard, Bernard Jouve, Jacques Berlan, Irme Ungi, Patrick Ohlmann, Jean Armengaud, Talib Majwal, Pierre Cazaux, Arif A.L. Noryani, Claude Cassat, O. Ormezzano, Didier Carrié, Hussam A. Noor

Publikováno v: JACC: Cardiovascular Interventions
JACC: Cardiovascular Interventions, Elsevier/American College of Cardiology, 2017, 10 (12), pp.1202-1210. ⟨10.1016/j.jcin.2017.03.049⟩

Objectives The aim of this study was to test the hypothesis that 6-month dual antiplatelet therapy (DAPT) is noninferior to 24-month DAPT in aspirin-sensitive patients. Background The ITALIC (Is There a Life for DES After Discontinuation of Clopidogr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::568efe475d3813e85a3d837589212009
https://doi.org/10.1016/j.jcin.2017.03.049

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Resistance to platelet antiaggregants: an important cause of very late thrombosis of drug eluting stents? Observations from five cases

Autor: J. Machecourt, Bernard Bertrand, G. Barone-Rochette, O. Ormezzano, Gérald Vanzetto, B. Polack

Publikováno v: Archives of cardiovascular diseases
Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2008, 101 (2), pp.100-7. ⟨10.1016/S1875-2136(08)70266-3⟩

International audience; BACKGROUND: Very late thrombosis of drug eluting stents is a rare complication that might be triggered by resistance to platelet antiaggregants (PAAs). AIM: Following an initial case where clinical data strongly suggested resi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8022c00f9be28e8a79722f39ec70ff5e